Oxygenta Pharmaceutical Schedules Board Meeting on 10th Nov'26 for Q2 Financial Results
Oxygenta Pharmaceutical Ltd 路 Intimation 路 10 Nov 2026, 5:30 am
Oxygenta Pharmaceutical Schedules Board Meeting on 10th Nov'26 for Q2 Financial Results Oxygenta Pharmaceutical Limited has scheduled a meeting of its Board of Directors on 10th Nov'26. The board will convene primarily to consider, approve, and take on record the company's un-audited financial results along with the Limited Review Report for the quarter and half-year ended 30th Sep'26.
Original exchange filing (PDF)
More announcements from Oxygenta Pharmaceutical Ltd
- Un-audited Financial Results for the Quarter and Half-year ended 30.09.2026. 路 10 Nov 2026
- Outcome of Board Meeting held on Tuesday i.e. 10th November, 2026. 路 10 Nov 2026
- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015. 路 01 Oct 2026
- Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015. 路 21 Aug 2026
- Outcome of 33rd Annual General Meeting held on 21.08.2026. 路 21 Aug 2026
- Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026. 路 31 Jul 2026
- Intimation of Book Closure and Cut-off Date for the AGM 路 30 Jul 2026
- Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015 路 30 Jul 2026
